Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia
Current Medical Research and Opinion, 07/15/09
Hernandez E et al. - In this study, fixed-dose Q3W darbepoetin alfa appeared to be well-tolerated and effective for the treatment of CIA.
Related Articles
Iron-Refractory Iron Deficiency Anemia
Seminars in Hematology, 10/05/09
Relevance Score: 94%
Fanconi Anemia Complementation Group FANCD2 Protein Serine 331 Phosphorylation Is Important for Fanconi Anemia Pathway Function and BRCA2 Interaction
Cancer Research, 11/17/09
Relevance Score: 91%
A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases
World Journal of Gastroenterology, 10/14/09
Relevance Score: 91%
Prevalence and pathogenesis of anemia in Inflammatory Bowel disease. Influence of anti-tumor necrosis factor-alpha treatment
Haematologica, 10/12/09
Relevance Score: 91%
Hereditary Sideroblastic Anemias: Pathophysiology, Diagnosis, and Treatment
Seminars in Hematology, 10/05/09
Relevance Score: 91%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/18/09
Probable levetiracetam-associated depression in the elderly: Two case reports
The American Journal of Geriatric Pharmacotherapy, 12/18/09
Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
Anesthesiology, 12/17/09
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
Milatuzumab – a promising new immunotherapeutic agent
Expert Opinion on Investigational Drugs, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


